Suppliers / Basf Se

Basf Se

Germany Updated 9 July 2026

Basf Se is an API manufacturer based in Germany. It holds 2 active US drug master files and 14 valid CEPs across a filed portfolio of 13 molecules. Its filings concentrate with EFDA (ET) and MINSA (CR). Its GMP standing is certified by ZLG (DE), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 29 August 2024 as VAI.

2
active US DMFs
14
valid CEPs
4
registered plants 1 with an FDA FEI number
2
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 29 August 2024 VAI US FDA
  • 16 September 2020 VAI US FDA
  • 13 July 2018 VAI US FDA
  • 10 March 2016 NAI US FDA
  • 27 June 2013 NAI US FDA
  • 17 March 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Germany, Germany 3002903906
Ludwigshafen, Germany Not on file
Rhineland-Palatinate, Germany Not on file
Ludwigshafen Am Rhein, Germany Not on file

What they file, and where

Molecule Regulators Docs
Levomenthol EDQM, SFDA (Saudi Arabia), US FDA 3
Dexpanthenol EDQM, SFDA (Saudi Arabia) 2
Povidone EDQM 2
Povidone-Iodine EDQM, US FDA 2
Calcium Pantothenate EDQM 1
Copovidone EDQM 1
Crospovidone EDQM 1
Dl-Alpha Tocopheryl Acetate EDQM 1
Dl-Alpha-Tocopherol EDQM 1
Ibuprofen EDQM 1
Show all 13 molecules on file
Phenoxyethanol EDQM 1
Riboflavin EDQM 1
Vitamin A EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EFDA (ET) 1 None
MINSA (CR) 1 None
ZLG (DE) None 6
EMA None 2
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Basf Se comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 19 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 29 August 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates